1 – 9 of 9
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Non-HLA angiotensin-type-1 receptor autoantibodies mediate the long-term loss of grafted neurons in Parkinson’s disease models
(
- Contribution to journal › Article
- 2023
-
Mark
Combined cell-based therapy strategies for the treatment of Parkinson's disease : Focus on mesenchymal stromal cells
(
- Contribution to journal › Scientific review
- 2021
-
Mark
Dose-dependent effect of mesenchymal stromal cells co-grafted with dopaminergic neurons in a Parkinson's disease rat model
(
- Contribution to journal › Article
-
Mark
Dopamine regulates adult neurogenesis in the ventricular-subventricular zone via dopamine D3 angiotensin type 2 receptor interactions
(
- Contribution to journal › Article
-
Mark
Nrf2 activation and downstream effects : Focus on parkinson’s disease and brain angiotensin
(
- Contribution to journal › Scientific review
- 2019
-
Mark
Interaction between angiotensin type 1, type 2, and mas receptors to regulate adult neurogenesis in the brain ventricular–subventricular zone
(
- Contribution to journal › Article
- 2018
-
Mark
Prostaglandin EP2 Receptors Mediate Mesenchymal Stromal Cell-Neuroprotective Effects on Dopaminergic Neurons
(
- Contribution to journal › Article
-
Mark
Angiotensin II induces oxidative stress and upregulates neuroprotective signaling from the NRF2 and KLF9 pathway in dopaminergic cells
(
- Contribution to journal › Article
-
Mark
Data on the effect of Angiotensin II and 6-hydroxydopamine on reactive oxygen species production, antioxidant gene expression and viability of different neuronal cell lines
(
- Contribution to journal › Article